openPR Logo
Press release

Oncology/Cancer Drugs Market by top key Players - AstraZeneca PLC,Johnson & Johnson (Janssen Global Services, LLC,),Novartis AG,Pfizer Inc.,F. Hoffmann-La Roche Ltd

06-07-2021 02:06 PM CET | Health & Medicine

Press release from: Research Report

Oncology/Cancer Drugs Market by top key Players - AstraZeneca

Oncology Drugs Market Overview:

The global oncology/cancer drugs market was valued at $97,401 million in 2017, and is estimated to reach at $176,509 million by 2025, registering a CAGR of 7.6% from 2018 to 2025.

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option to treat various cancer types, especially blood cancer (leukemia). Rise in incidence of various cancer conditions, increase in popularity of advance therapies (biological and targeted drug therapies), and surge in geriatric population worldwide are the key factors driving the growth of the global oncology/cancer drugs market. Furthermore, rise in cancer awareness and availability of cancer drugs are expected to boost the market growth.

PDF Sample for New Advancements with Applications : https://www.researchreport.co.uk/Request-Sample/101421

However, high cost involved in new drug development coupled with threat of failure & adverse effects associated with cancer drugs therapies is expected to restrain the growth of the market. Conversely, high potential of emerging economies and increase in number of pipeline products are expected to provide new opportunities for market players in future.Â

The global oncology/cancer drugs market is segmented based on drug class type, indication, and region. Depending on drug class type, the market is divided into chemotherapy, targeted therapy, immunotherapy (biologic therapy), and hormonal therapy. By indication, it is categorized into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer, and other cancers.Â
Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Benefits for Oncology Drugs Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

Request Discount for New Advancements with Applications @ https://www.researchreport.co.uk/Request-Discount/101421

It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.Â
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Oncology Drugs Key Market Segments:

By Drug Class TypeÂ

Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
By IndicationÂ

Lung Cancer
Stomach Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Esophagus Cancer
Cervical Cancer
Kidney Cancer
Bladder Cancer
Other Cancers
By Region

North America
U.S.

Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Japan
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
List of Key Players Profiled in the Report

AbbVie Inc.

Astellas Pharma Inc.

AstraZeneca PLC
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.

Johnson & Johnson (Janssen Global Services, LLC,)
Merck & Co., Inc.

Novartis AG
Pfizer Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

Sanofi
Amgen Inc.

Bayer AG
Exelixis, Inc.

Obtain Report Details @ https://www.researchreport.co.uk/Reports/Oncology-Cancer-Drugs-Market

Address - 109,,Stratford Street
Leeds, West Yorkshire,LS11JJG (UK)

Call us - +442037693786
Mail us - sales@researchreport.co.uk

Research Report UK ( A Division of Envision Research & Consulting) offers Premium quality market intelligence, market research, industry analysis reports and forecast data for different domains across the business industry. Research Report totally understands the importance of market analysis for any strategy implementation in any organization or association. In order to provide the quickest and the most dependable solution, Research Report have associated with major organizations within market research and consultancy firms.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology/Cancer Drugs Market by top key Players - AstraZeneca PLC,Johnson & Johnson (Janssen Global Services, LLC,),Novartis AG,Pfizer Inc.,F. Hoffmann-La Roche Ltd here

News-ID: 2299671 • Views: 314

More Releases from Research Report

Agrochemicals Market - Opportunity Analysis and Industry Forecast, 2019-2025
Overview of Agrochemicals Market A comprehensive evaluation of the Agrochemicals Market has been presented in the report for the forecasted period 2019 to 2025. In order to get a deep insight into the market, a wide range of segments have been covered in the report along with the thorough analysis of the key trends and the factors that impact the market. The main highlight of the report includes the key factors
In-vitro Inflammatory Bowel Disease Diagnostic Market By Top Players - Siemens H …
Overview of In-vitro Inflammatory Bowel Disease Diagnostic Market A comprehensive evaluation of the In-vitro Inflammatory Bowel Disease Diagnostic Market has been presented in the report for the forecasted period 2019 to 2025. In order to get a deep insight into the market, a wide range of segments have been covered in the report along with the thorough analysis of the key trends and the factors that impact the market. The main
Modular Data Center Market is projected to reach $59,971 million by 2027 & Oppor …
The rapidly deployable data center module or modular data center is a portable data center that helps to deploy data processing capacity. It offers scalable data center capacity along with a range of cooling and power options. The target customers for modular data center are overcrowded datacenter owners as well as those in necessity of huge mobile computing power, such as the military, Web 2.0 providers, physics labs, government, financial
Digital Transformation in BFSI Market By Technology (Artificial Intelligence, Cl …
Digital transformation is a method of using digital technology for changing current business approaches into more advance and technologically driven business approaches for increasing customer satisfaction and to enhance revenue opportunities. In addition to this, various banks, fintech and insurance companies are adopting digital banking platform for increasing transparency among the enterprises and to building more trust among the employees. Furthermore, various insurance companies across the globe are adopting digital

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and